These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 3763088)
1. Estrogen and progesterone receptors in uterine sarcomas. Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417 [TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer. Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579 [TBL] [Abstract][Full Text] [Related]
4. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Ciocca DR; Puy LA; Fasoli LC Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317 [TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
7. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
9. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance]. Kleine W; Fuchs A; deGregorio G; Geyer H Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560 [TBL] [Abstract][Full Text] [Related]
10. Improved measurement of androgen receptors in human breast cancer. Lea OA; Kvinnsland S; Thorsen T Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456 [TBL] [Abstract][Full Text] [Related]
11. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice. Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409 [TBL] [Abstract][Full Text] [Related]